Please login to the form below

Not currently logged in


This page shows the latest Janssen news and features for those working in and with pharma, biotech and healthcare.

J&J’s targeted bladder cancer treatment gets US approval

J&J’s targeted bladder cancer treatment gets US approval

patients in close consultation with the FDA," said Peter Lebowitz, Global Therapeutic Area Head, Oncology, Janssen Research &Development.

Latest news

More from news
Approximately 126 fully matching, plus 353 partially matching documents found.

Latest Intelligence

  • The first, my last, my everything The first, my last, my everything

    It’s a subtle but important nuance. It’s a similar story elsewhere, with companies like Roche, Janssen and MSD ‘partnering with patients’ to understand their needs and identify opportunities for

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Katrin Haeverans, EPAD LCS and POC platform support, Janssen said: “EPAD has been built to facilitate proof-of-concept trials. ... Sir Simon Lovestone. After 18 years in old age psychiatry and dementia research in academia, Sir Simon Lovestone joined

  • Deal Watch October 2018

    Product / Technology. Deal Type. Headline. ($). Arrowhead/. Janssen (J&J). Development &commercialisation of ARO‐HBV, based on.

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    The firm also has what it hopes is a best- in-class BTK inhibitor, zanubrutinib, in phase III trials, which it believes can be shown superior to Janssen’s Imbruvica.

  • The race for a HIV ‘cure’ The race for a HIV ‘cure’

    Gilead’s HIV work continues apace as does that of rivals GSK, Sanofi, Janssen and others in a global HIV drug market expected to reach a value of $26, 458bn in

More from intelligence
Approximately 5 fully matching, plus 47 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Attigo (part of the Mednet Group)

    Clinigen. Crohns and Colitis Department for International Development. Eisai. Gilead. Janssen.

  • Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

    We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in

  • Adelphi Research UK wins Agency of the Year at BHBIA Conference

    Adelphi, Janssen and Rethink Mental Illness pro-bono work wins BHBIA Best Conference Paper. ... Adelphi were already excited to work with Janssen and Rethink to generate findings around the Mental Health Act to help lobby government changes, but to have

  • No Voice, No Choice

    The research was commissioned by Rethink Mental Illness and undertaken by Adelphi Research UK, with support from Janssen Cilag Ltd. ... Rachel Medcalf, Managing Director, Adelphi Research UK commented:. “It’s great to be involved in this crucial

  • Synergy Vision

    Amgen. Daiichi Sankyo. GlaxoSmithKline. Janssen Cilag. LEO Pharma. The Menarini Group.

More from PMHub
Approximately 5 fully matching, plus 28 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...